A recently published study compiled interview responses from 20 patients who’ve been through the early liver transplant process at Johns Hopkins.

Johns Hopkins physician-researchers aim to make a key procedure safer.

Johns Hopkins hepatologists Doan Dao and James Hamilton, along with philanthropists Mai and Volker Dolch, aim to eradicate this primary driver of deadly liver cancer by 2030.

New research connects a genetic mutation in a subset of patients with Crohn’s disease to aberrant bile acid metabolism caused by dysregulation in a gut hormone. The discovery may create opportunities for treatment options.